Mutants of the hepatitis virus
Chalupa, P.; Jezek, P.; Husa, P.
Vnitrni Lekarstvi 41(6): 411-414
1995
ISSN/ISBN: 0042-773X PMID: 7676663 Document Number: 441077
The variability of genomes of the hepatitis viruses leads to the development of viral mutants which are of great importance not only for epidemiology and therapy but also for the prevention of infections they cause. Contemporary knowledge indicates that investigation of mutants of hepatitis viruses is not only necessary for the understanding of the epidemiology, spread, elucidation of the severity of the disease and sequelae after acute infection but also for our therapeutic possibilities in different forms of viral hepatitis (VH). The submitted paper reviews the most important mutants of different types of VH (HA, HB, HC, HD, and HE).
Document emailed within 1 workday
Related Documents
Wirth, S.; Gerner, P.; Friedt, M.; Lausch, E.; Truebel, H.; Winter, K. 1998: Hepatitis B virus mutants in HBsAg positive children Acta Gastro-Enterologica Belgica 61(2): 185-188Zabek, P.; Opoka-Kegler, J.; Baka, M.; Dyda, T.; Stańczak, G.P.; Stańczak, J.J. 2013: Prevalence of hepatitis C virus mutants resistant to protease inhibitors among Polish HCV genotype 1-infected patients Przeglad Epidemiologiczny 67(3): 411
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240
Devi, K.S.; Singh, N.B.; Singh, H.L.; Singh, Y.M. 2009: Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users Journal of the Indian Medical Association 107(3): 144; 146-147
Guido, M.; Rugge, M.; Colombari, R.; Cecchetto, A.; Scarpa, A.; Cadrobbi, P. 1998: Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C Italian Journal of Gastroenterology and Hepatology 30(4): 414-417
Woyciechowska, J.; Breschkin, A.M.; Rapp, F. 1977: Measles virus meningoencephalitis. Immunofluorescence study of brains infected with virus mutants Laboratory Investigation; a Journal of Technical Methods and Pathology 36(3): 233-236
Panlilio, A.L.; Shapiro, C.N.; Schable, C.A.; Mendelson, M.H.; Montecalvo, M.A.; Kunches, L.M.; Perry, S.W.; Edwards, J.R.; Srivastava, P.U.; Culver, D.H. 1995: Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group Journal of the American College of Surgeons 180(1): 16-24
Watson, R.J.; Clements, J.B. 1978: Virus transcript mapping studies in cells infected with temperature-sensitive mutants of herpes simples virus type 1 Iarc Scientific Publications 1978(24 Part 1): 313-326
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Lei, C.-l.; Huang, C.-h.; Yang, Z.; Tang, X.-p. 2007: Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(2): 108-110
Laufer, N.; Cassino, L.; Bolcic, F.; Moretti, F.; Reynoso, R.; Bouzas, M.B.; Cahn, P.; Salomón, H.; Quarleri, J. 2008: Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme Journal of Acquired Immune Deficiency Syndromes 49(2): 233-234
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112